Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-26-017406
Filing Date
2026-05-15
Accepted
2026-05-15 16:37:04
Documents
79
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20260331_10q.htm   iXBRL 10-Q 1264586
2 EXHIBIT 31.1 ex_959981.htm EX-31.1 7915
3 EXHIBIT 31.2 ex_959982.htm EX-31.2 8251
4 EXHIBIT 32.1 ex_959983.htm EX-32.1 3926
5 EXHIBIT 32.2 ex_959984.htm EX-32.2 3911
  Complete submission text file 0001437749-26-017406.txt   7849508

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA sdev-20260331.xsd EX-101.SCH 79047
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sdev-20260331_def.xml EX-101.DEF 547357
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE sdev-20260331_lab.xml EX-101.LAB 443435
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sdev-20260331_pre.xml EX-101.PRE 580062
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sdev-20260331_cal.xml EX-101.CAL 36253
83 EXTRACTED XBRL INSTANCE DOCUMENT nby20260331_10q_htm.xml XML 1252106
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
Stablecoin Development Corp (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 26988804
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)